Background & Summary {#Sec1}
====================

Skeletal muscle atrophy is the loss of muscle mass and function that occurs in response to diverse stimuli including disuse/immobility, glucocorticoid treatment, cancer, aging, and denervation^[@CR1]--[@CR5]^. Biologically, atrophy reflects the active loss of skeletal muscle contractile proteins, leading to loss of strength and functional impairment with substantial impact on quality of life and, in some cases, reduced survival^[@CR6]--[@CR8]^. In addition, chronically denervated, atrophied muscle shows impaired capacity for reinnervation and functional recovery, which significantly limits prospects for recovery in settings of chronic neuromuscular disease, delayed repair, or large nerve lesions^[@CR9]--[@CR12]^.

Nerve-evoked contraction is the most important factor for maintaining or regaining muscle mass and force^[@CR13]^. Neurogenic atrophy refers specifically to skeletal muscle atrophy resulting from denervation, as may occur in traumatic injury or diseases that affect the peripheral nervous system, such as amyotrophic lateral sclerosis (ALS)^[@CR14]--[@CR17]^. A number of "atrogenes" are induced as a result of denervation and in response to various triggers of muscle atrophy; among these are specific ubiquitin ligases targeting components of the sarcomere^[@CR18]--[@CR29]^. A comprehensive analysis of the global gene pathways that change in response to denervation and during atrophy may offer an optimal chance of identifying means to pharmacologically maintain or increase muscle mass and function in atrophy-associated disease states.

We provide here a comprehensive RNA-Seq dataset^[@CR30]^ to identify gene expression changes across the entire longitudinal course of muscle atrophy, affording the opportunity to (1) establish acute responses to denervation within the first day, (2) detect pathways that mediate rapid proteolysis and loss of muscle mass within the first week after denervation, and (3) capture the molecular phenotype of chronically atrophied muscle (weeks to months after denervation) at a stage when it is largely resistant to reinnervation and recovery.

We generated a longitudinal RNA-Seq dataset from a cohort of adult (8-week-old) wild type C57BL/6 J male mice denervated for 0 (baseline), 1, 3, 7, 14, 30, or 90 days (n = 4 for each timepoint)^[@CR30]^. We elected to use tibial nerve transection as a model for muscle denervation, as this approach is physiologically meaningful while limiting the morbidity (i.e., pain and immobility) associated with complete sciatic nerve transection^[@CR31]^. The tibial nerve is the largest branch of the sciatic nerve that supplies skeletal muscles of the posterior compartment of the lower limb, including the gastrocnemius and soleus. In brief, we identified and separated the tibial nerve from other branches of the sciatic nerve, then ligated, cut distally, and sutured the proximal stump in place to prevent muscle reinnervation during chronic studies. We have established that this model reliably induces significant gastrocnemius atrophy within one week after denervation, with atrophy becoming progressively more severe over time (Fig. [1c,d](#Fig1){ref-type="fig"}).Fig. 1Overview of the experimental procedure. The tibial nerve, the largest branch of the sciatic nerve, supplies the gastrocnemius muscle and other muscles of the lower limb posterior compartment. In our mouse model of denervation atrophy, the sciatic nerve is identified, and its branches separated to isolate the tibial nerve (**a**; nerve identities are as follows: 1, sural nerve; 2, tibial nerve; 3, common peroneal/fibular nerve; 4, sciatic nerve). We generated a cohort of C57BL/6 J male mice denervated for 0, 1, 3, 7, 14, 30, or 90 days (**b,c**). Significant atrophy is apparent by 7 days after denervation, with consistent decline in mass during chronic denervation (**d**); \*\*\**P* \< 0.001 compared to baseline.

The samples collected and described in this manuscript include transcriptional profiles from a total of 28 denervated gastrocnemii and 28 contralateral (paired) intact gastrocnemii, comprising 4 denervated and 4 contralateral (paired) intact gastrocnemii for each of 7 denervation durations \[0 (baseline), 1, 3, 7, 14, 30, and 90 days\]^[@CR30]^. All specimens were generated from a cohort of male C57BL/6 J mice that were 8 weeks of age at the start of the study. These data provide a comprehensive description of baseline gene expression in adult mouse skeletal muscle and a broad assessment of the acute and longitudinal gene expression changes in atrophying muscle associated with denervation.

Methods {#Sec2}
=======

Animal husbandry {#Sec3}
----------------

8-week-old C57BL/6 J male mice (Stock \#000664) were obtained from the Jackson Laboratory (Bar Harbor, ME) and randomized into 7 groups of n = 4 mice per group for the following denervation timepoints: 0, 1, 3, 7, 14, 30, and 90 days. Animal subjects were housed in a controlled environment with a 12:12-h light-dark cycle with ad libitum access to water and food (Envigo 2018 SX). All mouse experiments were carried out under protocols approved by the JHU Animal Care and Use Committee.

Tibial nerve denervation surgery {#Sec4}
--------------------------------

Mice were anesthetized with 1.5% isoflurane/2% oxygen using a VetEquip inhalation system (Livermore, CA). The left hindlimb was shaved and sterilized, and a 1 cm incision was introduced in the skin overlying the dorsal thigh. Myofascial planes were gently separated to reveal the sciatic nerve. The tibial nerve branch was identified at its distal branch point and gently separated from the sciatic and peroneal nerves, then ligated proximally and distally using a 10-0 polyamide monofilament suture. The tibial nerve was then transected, the nerve length between ligatures carefully resected, and the proximal stump sutured to the biceps femoris muscle to prevent distal reinnervation. The incision was then closed using stainless steel wound clips. Mice were monitored for recovery from anesthesia and then returned to their home cages.

Myofiber morphometry {#Sec5}
--------------------

Gastrocnemii were frozen in O.C.T. in liquid nitrogen-cooled isopentane, then sectioned at 10 μm. Mid-belly transverse sections were blocked with M.O.M. in PBS (1:40 dilution, Vector Laboratories, catalogue \#MKB-2213) at room temperature for 1 h, then incubated overnight at 4 °C with a mixture of BA-D5 supernatant (1:100, myosin heavy chain type I, SC-71 supernatant (1:100, myosin heavy chain type IIa), BF-F3 concentrate (1:100, myosin heavy chain type IIb) \[all from the Developmental Studies Hybridoma Bank (DSHB)\], and rat-anti-laminin (1:1000, Sigma, catalogue \#L0663) in 1% BSA/PBS. Sections were then washed 3 × 5 min in PBS and incubated with a mixture of the following secondary antibodies (all at 1:500) for 2 h at room temperature: goat-anti-mouse IgG2b-DyLight-405, IgG1-Alexa Fluor-488, IgM-Alexa Fluor-594 (all from Jackson ImmunoResearch, catalogue numbers 115-475-207, 115-545-205, and 115-585-075, respectively), and goat anti-rat-IgG-Alexa Fluor-647 (Thermo Fisher Scientific, catalogue \#A-21247), diluted in 1% BSA/PBS. Sections were washed 3 × 5 min in PBS and coverslipped using Prolong Gold antifade (Thermo Fisher Scientific, catalogue \#P36930). Transverse sections were imaged in their entirety using a Zeiss AxioObserver. Myofiber minimum Feret diameters were determined using Fiji (NIH)^[@CR32]^, with \~100 randomly selected myofibers of each fiber type (type I, II, or IIa) measured from each of 3 biological replicates for each indicated timepoint. Statistical analysis was performed using Stata v. 11.2 (College Station, TX)^[@CR33]^.

RNA Isolation {#Sec6}
-------------

Skeletal muscle was homogenized in TRIzol (Ambion, catalogue \#15596018) using RNase-free stainless steel beads (Next Advance, catalogue \#SSB02-RNA). Homogenates were centrifuged at 10,000 rpm at 4 °C for 10 min to pellet debris, and RNA was purified from the TRIzol supernatant using a Direct-Zol RNA mini purification kit with on-column DNase digestion (Zymo Research, catalogue \#R2072). RNA integrity (RIN) was assayed using an Agilent 2100 Bioanalyzer.

RNA-Seq library preparation, sequencing, and bioinformatics analysis {#Sec7}
--------------------------------------------------------------------

RNA-sequencing was carried out using TrueSeq RiboZero gold (stranded) kit (Illumina, catalogue \#20020597). Libraries were indexed and sequenced over 18 lanes using HiSeq4000 (Illumina) with 69-bp paired end reads. Quality control (QC) was performed on base qualities and nucleotide composition of sequences using FastQC version 0.11.5^[@CR34]^, to identify problems in library preparation or sequencing. Sequence quality for the dataset described here was sufficient that no reads were trimmed or filtered before input to the alignment stage. Paired-end reads were aligned to the most recent *Mus musculus* mm10 reference genome (GRCm38.75) using the STAR spliced read aligner (version 2.4.0)^[@CR35]^. Average input read counts were 58.0 M per sample (range 39.1 M to 91.0 M) and average percentage of uniquely aligned reads was 81.9% (range 72.3% to 88.6%). Total counts of read-fragments aligned to known gene regions within the mouse (mm10) refSeq (refFlat version 07.24.14) reference annotation were used as the basis for quantification of gene expression. Fragment counts were derived using HTSeq (version 0.6.0) and the mm10 refSeq transcript model^[@CR36]^. Low count transcripts were filtered, and count data were normalized using the method of trimmed mean of M-values (TMM)^[@CR37]^ followed by removing unwanted variation using Bioconductor package RUVseq^[@CR38]^ with k value of 1. Differentially expressed genes (FDR \< 0.1) were then identified using the Bioconductor package limma with voom function to estimate mean-variance relationship, followed by empirical Bayes moderation^[@CR39]--[@CR41]^. Pairwise comparisons between denervated and contralateral intact muscle at each timepoint were used as the basis for model contrasts. All bioinformatics analyses were conducted using R version 3.5.1^[@CR42]^.

Data Records {#Sec8}
============

Sequencing data in the fastq format have been deposited in NCBI Sequence Read Archive (SRA)^[@CR30]^. A metadata table (Supplementary Table [S1](#MOESM1){ref-type="media"}) is available with details for each sample.

Technical Validation {#Sec9}
====================

Reproducible skeletal muscle atrophy using tibial nerve denervation model {#Sec10}
-------------------------------------------------------------------------

Tibial nerve denervation resulted in a reliable time-dependent loss of skeletal muscle mass, with a significant difference in mass between denervated and contralateral intact gastrocnemii detected by day 7 post-denervation (Fig. [1c,d](#Fig1){ref-type="fig"}). All mice used in this study entered the cohort at the same time, with sequential denervation according to the designated timepoints, to remove age as a potential confounding variable. Mouse gastrocnemius contains a mixed population of myofiber types including so-called slow twitch myofibers (type I) and fast twitch myofibers (type IIa and IIb). After muscle denervation, all three of these myofiber populations showed a significant reduction in size as measured by minimum Feret diameter, with the most substantial rate of individual myofiber atrophy occurring within the first two weeks post-denervation (Fig. [2](#Fig2){ref-type="fig"}). Type IIb myofibers, the most abundant myofiber type in mouse gastrocnemius, showed the largest magnitude of atrophy (Fig. [2f](#Fig2){ref-type="fig"}). Multiple linear regression with myofiber type, myofiber type-time interactions, and time modeled with a spline at t = 14 days was used to model rates of atrophy among type I, IIa, and IIb myofibers; bootstrapping was used to estimate standard errors. Results are presented in Table [1](#Tab1){ref-type="table"}.Fig. 2Gastrocnemius myofiber morphometry. Atrophy of type I, IIa, and IIb myofibers was analyzed by assessment of minimum Feret diameter at baseline (t = 0 days) and 7, 14, 30, and 72 days post-denervation. All three myofiber types showed significant atrophy within the first week after denervation, with the greatest change in magnitude observed for type IIb myofibers overall. Scale bar, 100 μm.Table 1Myofiber type-dependent atrophy during acute and chronic denervation.0--14 days denervationΔ minimum Feret diameter (μm/day)standard error (μm/day)95% CI*P* (compared to type IIb)type IIb−3.030.07−3.16, −2.89---  IIa−0.800.04−0.90, −0.71\<0.0001  I−1.240.06−1.36, −1.13\<0.0001**\>14 days denervation**type IIb−0.170.01−0.19, −0.15---  IIa−0.110.01−0.14, −0.09\<0.0001  I−0.090.01−0.11, −0.06\<0.0001

RNA quality control {#Sec11}
-------------------

RNA integrity was analyzed using an Agilent 2100 Bioanalyzer (Fig. [3](#Fig3){ref-type="fig"}). The mean RNA Integrity Number (RIN) for RNA isolated from denervated and contralateral intact gastrocnemii was 7.8 ± 0.3 and 8.3 ± 0.1 (mean ± SEM), respectively, with no significant difference in RIN by denervation status.Fig. 3RNA integrity of samples. Following denervation for the designated durations, denervated and contralateral intact gastrocnemii were harvested and homogenized directly in TRIzol, and total RNA was column-purified. RNA samples were reverse-transcribed to cDNA and sequenced on an Illumina platform. Representative RIN tracings from one biological replicate of the cohort, showing total RNA isolated from intact gastrocnemii (**a**) and paired contralateral denervated gastrocnemii (**b**). RNA isolated from denervated and intact muscle showed similar quality (**c**).

Read quality and base-calling accuracy {#Sec12}
--------------------------------------

Read quality was high with Phred quality score \>70 for the majority of the cycles, and lower quartile base qualities were generally high (Fig. [4](#Fig4){ref-type="fig"}). No reads or samples necessitated exclusion based on read quality. The nucleotide composition patterns (proportions of A/C/G/T) of all samples were as expected, with nearly uniform proportions of each nucleotide across sequencing cycles (with the exception of a non-random pattern of nucleotide proportions in the first 13 sequencing cycles as a result of random hexamer priming) (Fig. [5](#Fig5){ref-type="fig"}). No read trimming or filtering was required because the quality distribution and variance appeared normal across all reads and samples.Fig. 4Read quality. Representative distribution of Phred quality scores at each nucleotide, shown for the paired reads of one biological replicate for contralateral intact (**a**) and denervated (**b**) muscle. The boxes indicate the mean, median, and lower and upper quartile.Fig. 5Alignment quality. Representative distribution of A (red), C (yellow), G (green), and T (blue) at each nucleotide, shown for the paired reads of one biological replicate for contralateral intact (**a**) and denervated (**b**) muscle.

Alignment quality {#Sec13}
-----------------

A summary of alignment statistics for all samples is provided in Tables [2](#Tab2){ref-type="table"}--[9](#Tab9){ref-type="table"}. Similar sequencing depths and mapping rates were observed for the denervated and contralateral intact skeletal muscle samples.Table 2Overall summary of alignments.CTLDN*P*\
(DN vs. CTL)\*Mean (SD),\
rangeMean (SD),\
rangeNumber of input reads5.71 × 10^7^ (8.50 × 10^6^)3.91 × 10^7^--7.75 × 10^7^5.90 × 10^7^ (1.15 × 10^7^)4.15 × 10^7^--9.10 × 10^7^0.49Average input read length138138---Number of uniquely mapped reads4.6 × 10^7^ (7.29 × 10^6^)3.17 × 10^7^--5.88 × 10^7^4.89 × 10^7^ (8.40 × 10^6^)3.57 × 10^7^--6.73 × 10^7^0.17Uniquely mapped reads (%)80.47 (3.75)73.85--85.9283.29 (3.99)72.3--88.620.009Average mapped length137.39 (0.42)136.10--137.71137.45 (0.41)135.93--137.710.58Number of splices: Total1.62 × 10^7^ (4.93 × 10^6^)5.67 × 10^6^--2.45 × 10^7^1.72 × 10^7^ (3.35 × 10^6^)1.00 × 10^7^--2.38 × 10^7^0.37Number of splices: Annotated (sjdb)1.60 × 10^7^ (4.91 × 10^6^)5.51 × 10^6^--2.43 × 10^7^1.70 × 10^7^ (3.33 × 10^6^)9.86 × 10^6^--2.35 × 10^7^0.38Number of splices: GT/AG1.61 × 10^7^ (4.90 × 10^6^)5.59 × 10^6^--2.44 × 10^7^1.71 × 10^7^ (3.33 × 10^6^)9.92 × 10^6^--2.36 × 10^7^0.38Number of splices: GC/AG9.38 × 10^4^ (2.83 × 10^4^)3.37 × 10^4^--1.42 × 10^5^1.09 × 10^5^ (13.37 × 10^4^)7.05 × 10^4^--1.52 × 10^5^0.03Number of splices: AT/AC7.31 × 10^3^ (2.18 × 10^3^)2.46 × 10^3^--1.13 × 10^4^9.38 × 10^3^ (1.95 × 10^3^)5.41 × 10^3^--1.49 × 10^4^0.0004Number of splices: Non-canonical2.79 × 10^4^ (8.77 × 10^3^)1.44 × 10^4^--4.91 × 10^4^2.77 × 10^4^ (8.62 × 10^3^)1.76 × 10^4^--5.24 × 10^4^0.92Mismatch rate per base (%)0.28 (0.14)0.15--0.660.25 (0.12)0.15--0.680.32Deletion rate per base (%)0.002 (0.004)0--0.010.001 (0.004)0--0.010.49Deletion average length1.68 (0.32)1.35--2.661.72 (0.29)1.41--2.780.65Insertion rate per base (%)0.005 (0.008)0--0.030.003 (0.007)0--0.030.38**Multi-Mapping Reads:**Number of reads mapped to multiple loci7.09 × 10^6^ (1.34 × 10^6^)4.89 × 10^6^--1.03 × 10^7^6.32 × 10^6^ (2.01 × 10^6^)3.27 × 10^6^--1.29 × 10^7^0.10% of reads mapped to multiple loci12.46 (1.65)9.61--15.8710.64 (2.15)7.26--16.890.0008Number of reads mapped to too many loci6.16 × 10^5^ (4.96 × 10^5^)1.31 × 10^5^--1.98 × 10^6^4.85 × 10^5^ (3.25 × 10^5^)1.45 × 10^5^--1.66 × 10^6^0.25**Unmapped Reads:**% of reads unmapped: too many mismatches00---% of reads unmapped: too short5.32 (2.21)2.99--11.824.71 (2.29)2.63--13.220.32^\*^Welch's t-test.Table 3Day 0 (baseline) alignments.CTL-0-1CTL-0-2CTL-0-3CTL-0-4DN-0-1DN-0-2DN-0-3DN-0-4Number of input reads55,742,41555,520,60955,035,74763,030,55561,655,19346,879,30268,278,35390,993,687Average input read length138138138138138138138138Number of uniquely mapped reads44,288,33042,269,60646,785,17352,763,03949,365,74536,068,97356,573,59365,791,821Uniquely mapped reads (%)79.4576.1385.0183.7180.0776.9482.8672.30Average mapped length137.29136.1137.64137.57137.2137.61137.61135.93Number of splices: Total13,449,62811,337,80017,752,38019,213,53613,937,30315,460,97723,318,21422,103,629Number of splices: Annotated (sjdb)13,279,96411,188,95217,562,68718,981,11113,722,59515,257,24323,063,15221,856,608Number of splices: GT/AG13,338,07511,231,53217,622,78019,059,81013,811,90515,337,67523,148,26821,924,998Number of splices: GC/AG79,14170,961100,965116,59783,25493,607131,002128,493Number of splices: AT/AC6,6135,4707,8148,7797,2047,56910,12710,049Number of splices: Non-canonical25,79929,83720,82128,35039,94022,12628,81740,089Mismatch rate per base (%)0.320.640.190.210.310.220.190.68Deletion rate per base (%)0.000.010.000.000.000.000.000.01Deletion average length1.842.661.551.591.651.461.562.78Insertion rate per base (%)0.010.030.000.000.010.000.000.03**Multi-Mapping Reads:**Number of reads mapped to multiple loci7,297,2466,213,0495,623,2936,892,9067,920,7307,915,6207,813,51512,905,331% of reads mapped to multiple loci13.0911.1910.2210.9412.8516.8911.4414.18Number of reads mapped to too many loci582,753255,211341,804568,680987,746539,784463,089172,576**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short5.6311.823.693.954.634.624.6613.22Table 4Day 1 post-denervation alignments.CTL-1-1CTL-1-2CTL-1-3CTL-1-4DN-1-1DN-1-2DN-1-3DN-1-4Number of input reads61,636,87258,072,07755,973,09671,794,34458,034,87648,989,93173,886,62274,271,951Average input read length138138138138138138138138Number of uniquely mapped reads45,746,32547,654,85648,094,86658,843,89048,750,12039,908,06162,480,23556,047,037Uniquely mapped reads (%)74.2282.0685.9281.9684.0081.4684.5675.46Average mapped length137.34137.47137.57137.6137.62137.59137.57136.25Number of splices: Total9,070,91116,321,20018,716,28724,549,73817,994,49013,613,41423,080,27317,817,564Number of splices: Annotated (sjdb)8,836,38416,122,23318,519,78324,297,36117,785,15813,408,13522,808,43117,582,261Number of splices: GT/AG8,966,85116,190,88718,583,61424,365,74317,858,25513,494,72222,900,17617,663,375Number of splices: GC/AG50,71396,907103,605141,926103,87783,585134,880108,178Number of splices: AT/AC4,2557,4668,26711,2768,3276,87811,0308,758Number of splices: Non-canonical49,09225,94020,80130,79324,03128,17934,18737,253Mismatch rate per base (%)0.400.260.230.170.190.250.210.63Deletion rate per base0.010.000.000.000.000.000.000.01Deletion average length1.371.631.841.711.491.451.662.4Insertion rate per base0.000.010.000.010.000.000.000.02**Multi-Mapping Reads:**Number of reads mapped to multiple loci9,782,7056,777,4465,377,7728,642,6056,176,5215,844,0147,396,7199,668,787% of reads mapped to multiple loci15.8711.679.6112.0410.6411.9310.0113.02Number of reads mapped to too many loci1,984,894619,936341,393194,108530,916812,052596,417413,918**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short5.124.553.445.553.794.174.1310.71Table 5Day 3 post-denervation alignments.CTL-3-1CTL-3-2CTL-3-3CTL-3-4DN-3-1DN-3-2DN-3-3DN-3-4Number of input reads43,601,76739,051,34660,982,53277,529,16761,614,60948,980,17077,233,03249,001,916Average input read length138138138138138138138138Number of uniquely mapped reads32,795,16931,708,28051,656,26458,276,50548,300,39840,533,61567,261,85340,543,472Uniquely mapped reads (%)75.2281.2084.7175.1778.3982.7687.0982.74Average mapped length137.18137.54137.63136.29137.27137.61137.58137.7Number of splices: Total7,641,73214,023,14919,917,67620,730,82412,188,89315,689,66023,843,24218,125,528Number of splices: Annotated (sjdb)7,481,95613,875,66219,704,84420,503,65911,912,73015,485,35523,536,88817,920,443Number of splices: GT/AG7,559,26913,909,11019,774,05920,569,91412,051,29015,551,27223,642,78717,982,044Number of splices: GC/AG44,92289,610110,632117,09276,969104,920151,795114,053Number of splices: AT/AC3,7516,8278,9199,8648,21710,33314,85911,510Number of splices: Non-canonical33,79017,60224,06633,95452,41723,13533,80117,921Mismatch rate per base (%)0.370.180.180.570.350.200.210.15Deletion rate per base0.000.000.000.010.010.000.000.00Deletion average length1.451.931.542.641.411.761.741.65Insertion rate per base0.000.010.000.020.000.000.000.00**Multi-Mapping Reads:**Number of reads mapped to multiple loci5,971,1344,893,8126,531,89110,323,3338,224,6405,219,4486,412,4476,047,917% of reads mapped to multiple loci13.6912.5310.7113.3213.3510.668.3012.34Number of reads mapped to too many loci1,070,563150,149453,705168,9491,656,313391,356516,587143,641**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short7.355.563.2811.174.335.333.354.41Table 6Day 7 post-denervation alignments.CTL-7-1CTL-7-2CTL-7-3CTL-7-4DN-7-1DN-7-2DN-7-3DN-7-4Number of input reads60,590,61056,143,55852,019,27551,496,20159,955,86252,135,01456,347,86049,238,405Average input read length138138138138138138138138Number of uniquely mapped reads44,746,34945,413,96543,059,55841,428,22848,787,07744,968,95948,225,33341,382,042Uniquely mapped reads (%)73.8580.8982.7880.4581.3786.2585.5984.04Average mapped length137.59137.52137.55137.52137.54137.62137.62137.71Number of splices: Total14,703,98016,917,30615,994,82419,253,85618,108,36717,195,99519,296,26617,537,132Number of splices: Annotated (sjdb)14,509,68816,698,11715,827,80619,075,52117,848,55516,979,72619,078,13917,331,026Number of splices: GT/AG14,581,73616,782,95815,879,43119,119,49317,951,60617,055,43619,144,65617,402,247Number of splices: GC/AG87,62994,17590,057109,413113,654107,871121,143107,129Number of splices: AT/AC6,9827,2596,7138,33511,44410,33110,95110,114Number of splices: Non-canonical27,63332,91418,62316,61531,66322,35719,51617,642Mismatch rate per base (%)0.230.250.240.200.210.190.230.16Deletion rate per base0.000.000.000.000.000.000.000.00Deletion average length1.461.61.551.661.51.681.611.58Insertion rate per base0.000.000.000.010.000.000.000.00**Multi-Mapping Reads**:Number of reads mapped to multiple loci9,428,2466,672,2055,740,0426,966,7637,352,3274,543,2025,722,8485,194,049% of reads mapped to multiple loci15.5611.8811.0313.5312.268.7110.1610.55Number of reads mapped to too many loci819,014789,365391,842166,663716,324332,671233,636243,367**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short8.415.234.835.534.513.913.514.58Table 7Day 14 post-denervation alignments.CTL-14-1CTL-14-2CTL-14-3CTL-14-4DN-14-1DN-14-2DN-14-3DN-14-4Number of input reads49,441,64669,876,92457,832,49747,973,29955,891,42944,966,50959,715,01654,942,368Average input read length138138138138138138138138Number of uniquely mapped reads36,913,92657,899,59548,950,62338,979,82646,402,58539,850,07451,086,87647,212,433Uniquely mapped reads (%)74.6682.8684.6481.2583.0288.6285.5585.93Average mapped length136.42137.57137.64137.71137.43137.6137.26137.64Number of splices: Total5,674,22821,316,99117,945,54818,202,91514,603,77813,578,93817,163,85119,981,473Number of splices: Annotated (sjdb)5,507,05821,070,68217,756,78218,029,15814,378,27613,404,59816,946,76119,745,905Number of splices: GT/AG5,594,71721,157,48017,811,04118,071,86114,465,58213,467,59117,016,21819,822,262Number of splices: GC/AG33,738117,529105,892108,30997,38986,275114,337126,876Number of splices: AT/AC2,4608,9337,6818,3768,4157,2299,54011,690Number of splices: Non-canonical43,31333,04920,93414,36932,39217,84323,75620,645Mismatch rate per base (%)0.660.220.190.150.230.210.300.17Deletion rate per base0.010.000.000.000.000.000.000.00Deletion average length1.961.531.491.541.61.731.771.81Insertion rate per base0.020.000.000.000.000.000.000.00**Multi-Mapping Reads:**Number of reads mapped to multiple loci6,729,8028,099,8026,448,8166,968,3575,711,9633,266,2555,086,8575,109,283% of reads mapped to multiple loci13.6111.5911.1514.5310.227.268.529.30Number of reads mapped to too many loci1,288,797704,083369,246131,113711,573285,356277,105152,218**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short7.923.982.993.774.722.934.974.27Table 8Day 30 post-denervation alignments.CTL-30-1CTL-30-2CTL-30-3CTL-30-4DN-30-1DN-30-2DN-30-3DN-30-4Number of input reads52,742,87846,463,40357,501,21960,468,55373,590,72748,399,32251,665,57954,577,655Average input read length138138138138138138138138Number of uniquely mapped reads40,308,92438,146,89648,521,24749,438,87258,520,85241,879,30345,337,49446,751,912Uniquely mapped reads (%)76.4382.1084.3881.7679.5286.5387.7585.66Average mapped length137.26137.46137.68137.65137.6137.5137.65137.55Number of splices: Total9,002,16412,162,16217,453,82421,318,00519,800,20214,238,82217,245,13817,175,362Number of splices: Annotated (sjdb)8,779,54111,999,10217,264,63421,090,38719,528,56714,056,75017,044,05916,948,110Number of splices: GT/AG8,902,80712,063,47317,319,77021,157,40919,623,21714,122,31517,105,74517,027,539Number of splices: GC/AG50,01369,863105,703125,956132,94788,561112,478111,959Number of splices: AT/AC4,1295,4397,9899,58711,1336,8768,9579,017Number of splices: Non-canonical45,21523,38720,36225,05332,90521,07017,95826,847Mismatch rate per base (%)0.410.340.180.180.210.230.160.22Deletion rate per base0.010.000.000.000.000.000.000.00Deletion average length1.351.541.521.541.592.11.611.85Insertion rate per base0.000.000.000.000.000.010.000.01**Multi-Mapping Reads:**Number of reads mapped to multiple loci7,401,2845,478,2486,190,6008,046,2938,580,9504,181,4324,632,1805,281,885% of reads mapped to multiple loci14.0311.7910.7713.3111.668.648.979.68Number of reads mapped to too many loci1,771,867704,627353,874396,886672,558312,239158,758369,051**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short4.843.823.703.987.273.682.633.59Table 9Day 90 post-denervation alignments.CTL-90-1CTL-90-2CTL-90-3CTL-90-4DN-90-1DN-90-2DN-90-3DN-90-4Number of input reads60,873,62947,878,30964,409,58964,474,03067,574,02841,457,41756,366,23164,290,975Average input read length138138138138138138138138Number of uniquely mapped reads48,591,92136,558,40654,742,09152,310,64855,842,21535,688,42749,296,56656,228,095Uniquely mapped reads (%)79.8276.3684.9981.1382.6486.0887.4687.46Average mapped length137.54137.33137.65137.54137.46137.62137.69137.56Number of splices: Total17,976,0869,096,03119,807,12923,581,45314,738,62410,009,83616,531,73517,148,016Number of splices: Annotated (sjdb)17,769,2058,892,79419,598,02323,349,41514,498,4309,862,71616,325,79216,910,940Number of splices: GT/AG17,834,6849,003,29519,661,02223,405,84014,592,6389,915,22216,382,46416,990,053Number of splices: GC/AG108,12648,499114,242134,946101,00570,463117,425118,687Number of splices: AT/AC8,7613,7818,57410,4327,9685,4109,2479,501Number of splices: Non-canonical24,51540,45623,29130,23537,01318,74122,59929,775Mismatch rate per base (%)0.200.410.190.190.250.210.170.22Deletion rate per base0.000.010.000.000.010.000.000.00Deletion average length1.751.371.521.961.611.551.671.88Insertion rate per base0.010.000.000.010.010.000.000.00**Multi-Mapping Reads:**Number of reads mapped to multiple loci7,924,8887,093,3136,681,3038,439,4576,752,7693,853,4305,037,8285,238,591% of reads mapped to multiple loci13.0214.8210.3713.099.999.298.948.15Number of reads mapped to too many loci469,2501,545,968447,456176,878855,527419,702172,340444,439**Unmapped Reads:**% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00% of reads unmapped: too short5.924.163.345.345.232.772.883.10

Counts per gene {#Sec14}
---------------

The distribution of normalized gene accounts appears similar among all samples in the dataset (Fig. [6](#Fig6){ref-type="fig"}).Fig. 6Summary of read counts. Density plot showing relative read count distributions for all samples.

Unsupervised clustering analysis of longitudinally denervated samples {#Sec15}
---------------------------------------------------------------------

Multidimensional scaling using expression levels of all genes demonstrated temporal clustering based on denervation status, with replicates within each denervation timepoint clustering closer to each other than to other denervation timepoints (Fig. [7](#Fig7){ref-type="fig"}).Fig. 7Quality of replicates. Multi-dimensional scaling analysis (**a**) and cluster dendrogram (**b**) of transcriptional profiles during neurogenic atrophy shows temporal clustering by denervation status.

Time-dependent comparison of denervated and contralateral intact skeletal muscle transcriptomes {#Sec16}
-----------------------------------------------------------------------------------------------

Normalized gene counts from denervated and contralateral intact skeletal muscle at each timepoint are compared in scatter plots (Fig. [8](#Fig8){ref-type="fig"}).Fig. 8Gene expression visualization. Scatterplots showing the log2 transform of normalized counts.

Differential expression analysis {#Sec17}
--------------------------------

MA-plots showing the log-fold change (M-values, the log of the ratio of counts for each gene across the two samples being compared) against the normalized log-average (A-values, the average counts for each gene across the two samples being compared) indicate substantial differences in gene expression in skeletal muscle during acute and chronic neurogenic atrophy (Fig. [9a--g](#Fig9){ref-type="fig"}). Volcano plots indicate minimal differences in gene expression at baseline (intact muscle) (Fig. [9h](#Fig9){ref-type="fig"}), but demonstrate that thousands of genes are significantly differentially expressed (FDR \< 0.1) within the first day after denervation (Fig. [9i](#Fig9){ref-type="fig"}) and beyond (Fig. [9j--n](#Fig9){ref-type="fig"}). A summary of the number of differentially expressed genes at each timepoint is shown in Fig. [9o](#Fig9){ref-type="fig"}.Fig. 9Differential expression analysis. MA-plots comparing the log2 fold change of gene expression for denervated vs. contralateral intact skeletal muscle at each timepoint plotted against the normalized average of the counts (**a**--**g**). Volcano plots showing the -log10 FDR for difference in expression between denervated and contralateral intact skeletal muscle for each gene detected, plotted against the log2 fold-change (**h**--**n**). Genes with FDR \< 0.1 are depicted in red. The total number of significantly differentially expressed genes (FDR \< 0.1) at each timepoint is summarized in panel (o).

Usage Notes {#Sec18}
===========

The RNA-Seq dataset presented in this study provides a detailed view of the acute and chronic gene expression changes that occur in denervated, atrophying skeletal muscle. These data may provide insight into the early events associated with acute loss of neuronal input that trigger rapid atrophy, as well as the gene expression changes in chronically denervated and severely atrophied skeletal muscle associated with impaired capacity for reinnervation. Defining these changes may afford opportunities to limit the rate and severity of skeletal muscle atrophy, and to enhance functional reinnervation.
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